The Company specializes in advances in Supplements for Health, and Anti-Aging with a special interest in Preventative Medicine. The Company was formed to distribute nutraceuticals formulas developed over thirty years of research by Dr. Kevin Buckman. Dr. Buckman has created more than a dozen fucoidan-based formulas which are intended to address the needs of individuals suffering from DDS (Degenerative Disease Syndrome), which includes such maladies as gastrointestinal disorders, auto-immune diseases, asthma, Alzeimer's, dementia, diabetes, arthritis, cancer, and heart disease.
The Company is focused on delivering nutraceutical formulas that can help diabetes and heart disease, along with new diagnostics for early detection of a predisposition to these disease states. Recognition of diabetes and vascular-cardiac disease is a very important part of this program since over one half of men and women have significant cardiovascular disease and millions of Americans have Diabetes and don?t know it.
The growing concerns of oxidative stress have been shown to be an etiology of these diseases. There is also growing evidence of the benefits from the correct anti-oxidant in a bio-available and effective delivery system. Handling of oxidative stress of the 50 billion cells of each of us is vital for quality of life and longevity. Peak performance and feeling of vitality is another important goal of The Company.
Our mission is to provide medically proven modalities for Diabetes and assist lowering the costs of most expensive medical disorders in the United States and Worldwide. Diabetes and Heart Disease is increasing in frequency throughout the world at a rapid rate, they are related as inflammatory diseases and the most costly problem and biggest killers in the US. Current allopathic therapy is severely lacking in ability to provide sick care and preventive medical practices.
Today the most costly medical problems we have are due to diabetes, heart disease, and cancer. Delivering products that provide better education for our customers that utilize scientifically-based testing is the most important service we can offer. The proper focus for Chronic Diseases such as Diabetes and Heart Disease is centered on the proper metabolic pathways. The goal for Diabetes is not just control of the blood sugar. The goal for cardiac disease is not just good cholesterol levels. Both Diabetes and Heart Disease require more control over cellular and metabolic pathways that are responsible for the health of every person suffering from these diseases. All of our products have been designed to help a variety of people by providing them a feeling of better wellness.
OTC Markets Group Inc. (“OTC Markets”) has discontinued the display of quotes on www.otcmarkets.com for this security because it has been labeled Caveat Emptor (Buyer Beware) for one of the following reasons:
Promotion/Spam without Adequate Current Information — The security is being promoted to the public, but adequate current information about the issuer has not been made available to the public. OTC Markets believes adequate current information must be publicly available during any period when a security is the subject of ongoing promotional activities having the effect of encouraging trading of the issuer's securities. At such instances, as a matter of policy, when adequate current information is not made available, OTC Markets will label the security as "Caveat Emptor." Promotional activities may include spam email, unsolicited faxes or news releases, whether they are published by the issuer or a third party.
Investigation of Fraud or Other Criminal Activities — There is an investigation of fraudulent or other criminal activity involving the company, its securities or insiders. When OTC Markets becomes aware of such investigation, the companies’ securities may be subject to Caveat Emptor.
Suspension/Halt — A regulatory authority or an exchange has halted or suspended trading for public interest concerns (i.e. not a news or earnings halt).
Undisclosed Corporate Actions — The security or issuer is the subject of a corporate action, such as a reverse merger, stock split, or name change, without adequate current information being publicly available.
Unsolicited Quotes — The security has only been quoted on an unsolicited basis since it entered the public markets and the issuer has not made adequate current information available to the public.
Other Public Interest Concern — OTC Markets has determined that there is a public interest concern regarding the security. Such concerns may include but are not limited to promotion, spam or disruptive corporate actions even when adequate current information is available.